GILDER GAGNON HOWE & CO LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2022$358,874
+398.4%
96,993
-0.0%
0.01%
+600.0%
Q3 2022$72,000
-5.3%
97,019
-0.8%
0.00%0.0%
Q2 2022$76,000
-14.6%
97,827
-0.0%
0.00%0.0%
Q1 2022$89,000
-99.2%
97,851
-92.9%
0.00%
-98.4%
Q4 2021$11,047,000
+14.5%
1,379,123
+19.6%
0.06%
+26.0%
Q3 2021$9,650,000
+176.0%
1,152,912
+122.3%
0.05%
+194.1%
Q2 2021$3,496,000518,7330.02%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders